WAY-169916

N/A

Report date: 2023/05/17 16:11:21

NME

Base Information

Drug NameWAY-169916

Drug Alias NameWAY-169916

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionEstrogen receptors modulators

TargetsEstrogen receptors

Therapy Area/IndicationsArthritis, Rheumatoid

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsArthritis, Rheumatoid

ATC CodeN/A